Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis

Oncology

Volumn 61, Issue 4, 2001, Pages 315-322

  Shimo, Tsuyoshi ^a   Nakanishi, Tohru ^a   Nishida, Takashi ^a,b   Asano, Masahiro ^a   Sasaki, Akira ^a   Kanyama, Manabu ^a   Kuboki, Takuo ^a   Matsumura, Tomohiro ^a   Takigawa, Masaharu ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Connective tissue growth factor; Neovascularization

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 8; CANCER GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; GENE PRODUCT; MESSENGER RNA; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VASCULOTROPIN;

ANGIOGENESIS; AORTA; ARTICLE; BREAST CANCER; CARTILAGE CELL; CATTLE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FIBROSARCOMA; HUMAN; HUMAN CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION; XENOGRAFT;

ALLANTOIS; ANIMALS; AORTA; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CATTLE; CHICKENS; CHORION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSARCOMA; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035204435     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055339     Document Type: Article

References (37)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Regulators of angiogenesis
4. The modular architecture of a new family of growth regulators related to connective tissue growth factor
5. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
6. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor
7. Cloning of mRNA preferentially expressed in chondrocyte by differential display PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA
8. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture
9. Expression of cyr61, a growth factor-inducible immediate-early gene
10. Identification of a phorbol ester-repressible v-src-inducible gene
11. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells
12. Connective tissue growth factor induces the proliferation, migration and tube formation of vascular endothelial cells in vitro and angiogenesis in vivo
13. Characterization of a newly derived human sarcoma cell line (HT-1080)
14. Breast tumor cell lines from pleural effusions
15. In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
17. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia
18. Tumor angiogenesis and polyamines: α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro
19. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
20. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
21. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
22. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model
23. Spatial and temporal expression of angiogenic molecules during tumor growth and progression
24. Requirement of vascular integrin αvβ3 for angiogenesis
25. αvβ3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells
26. Definition of two angiogenic pathways by distinct alpha v integrins
27. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alpha v beta 3, promotes endothelial cell survival, and induces angiogenesis in vivo
28. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concept of angiostatic therapy from intravital videomicroscopy
29. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor
30. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
31. Vascular endothelial growth factor is a secreted angiogenic mitogen
32. Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8
33. Recent developments in the cell biology of basic fibroblast growth factor
34. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
35. The influence of elevated levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase on tumourigenicity, tumour growth, and oxygenation
36. Angiogenin antagonists prevent tumor growth in vivo
37. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine